AmerisourceBergen Corp. (NYSE:ABC) Chairman Steven H. Collis sold 15,000 shares of the stock in a transaction on Monday, October 17th. The shares were sold at an average price of $79.59, for a total value of $1,193,850.00. Following the sale, the chairman now owns 231,252 shares of the company’s stock, valued at approximately $18,405,346.68. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of AmerisourceBergen Corp. (NYSE:ABC) opened at 81.09 on Wednesday. The stock has a market cap of $17.41 billion, a P/E ratio of 10.94 and a beta of 0.74. The company’s 50-day moving average is $83.07 and its 200-day moving average is $82.69. AmerisourceBergen Corp. has a 12-month low of $73.31 and a 12-month high of $105.81.

AmerisourceBergen Corp. (NYSE:ABC) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $1.37 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.10. The business had revenue of $36.90 billion for the quarter, compared to the consensus estimate of $36.57 billion. AmerisourceBergen Corp. had a net margin of 1.14% and a return on equity of 83.93%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.20 EPS. On average, equities research analysts anticipate that AmerisourceBergen Corp. will post $5.55 earnings per share for the current year.

Insider Buying and Selling by Quarter for AmerisourceBergen Corp. (NYSE:ABC)

ABC has been the subject of a number of research analyst reports. Avondale Partners upgraded AmerisourceBergen Corp. from a “market perform” rating to an “outperform” rating in a report on Tuesday, October 4th. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $98.00 price target on shares of AmerisourceBergen Corp. in a research note on Friday, August 26th. Leerink Swann reaffirmed a “buy” rating and issued a $100.00 price target on shares of AmerisourceBergen Corp. in a research note on Friday, October 7th. Zacks Investment Research downgraded shares of AmerisourceBergen Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, August 9th. Finally, FBR & Co upped their price target on shares of AmerisourceBergen Corp. from $84.00 to $90.00 and gave the stock a “mkt perform” rating in a research note on Wednesday, August 3rd. Ten investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $96.61.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Synovus Financial Corp increased its position in shares of AmerisourceBergen Corp. by 0.4% in the second quarter. Synovus Financial Corp now owns 5,431 shares of the company’s stock worth $430,000 after buying an additional 22 shares during the last quarter. Bruderman Asset Management LLC increased its position in shares of AmerisourceBergen Corp. by 1.1% in the second quarter. Bruderman Asset Management LLC now owns 2,620 shares of the company’s stock worth $208,000 after buying an additional 29 shares during the last quarter. Investors Capital Advisory Services increased its position in shares of AmerisourceBergen Corp. by 1.1% in the second quarter. Investors Capital Advisory Services now owns 2,860 shares of the company’s stock worth $226,000 after buying an additional 30 shares during the last quarter. HM Payson & Co. increased its position in shares of AmerisourceBergen Corp. by 0.9% in the second quarter. HM Payson & Co. now owns 3,438 shares of the company’s stock worth $272,000 after buying an additional 30 shares during the last quarter. Finally, HL Financial Services LLC increased its position in shares of AmerisourceBergen Corp. by 1.2% in the second quarter. HL Financial Services LLC now owns 2,949 shares of the company’s stock worth $234,000 after buying an additional 34 shares during the last quarter. 66.15% of the stock is currently owned by institutional investors and hedge funds.

AmerisourceBergen Corp. Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers.

5 Day Chart for NYSE:ABC

Receive News & Stock Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related stocks with our FREE daily email newsletter.